Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner.
Julien N BiancoValérie BergoglioYea-Lih LinMarie-Jeanne PillaireAnne-Lyne SchmitzJulia GilhodesAmelie LusqueJulien MazièresMagali Lacroix-TrikiTheodoros I RoumeliotisJyoti ChoudharyJérôme MoreauxJean-Sebastien HoffmannHélène TourrièrePhilippe PaseroPublished in: Nature communications (2019)
Oncogene-induced replication stress (RS) promotes cancer development but also impedes tumor growth by activating anti-cancer barriers. To determine how cancer cells adapt to RS, we have monitored the expression of different components of the ATR-CHK1 pathway in primary tumor samples. We show that unlike upstream components of the pathway, the checkpoint mediators Claspin and Timeless are overexpressed in a coordinated manner. Remarkably, reducing the levels of Claspin and Timeless in HCT116 cells to pretumoral levels impeded fork progression without affecting checkpoint signaling. These data indicate that high level of Claspin and Timeless increase RS tolerance by protecting replication forks in cancer cells. Moreover, we report that primary fibroblasts adapt to oncogene-induced RS by spontaneously overexpressing Claspin and Timeless, independently of ATR signaling. Altogether, these data indicate that enhanced levels of Claspin and Timeless represent a gain of function that protects cancer cells from of oncogene-induced RS in a checkpoint-independent manner.
Keyphrases
- dna damage
- papillary thyroid
- cell cycle
- high glucose
- diabetic rats
- squamous cell
- drug induced
- induced apoptosis
- electronic health record
- signaling pathway
- cell proliferation
- poor prognosis
- big data
- cell cycle arrest
- squamous cell carcinoma
- endothelial cells
- machine learning
- childhood cancer
- transcription factor
- cell death
- young adults
- binding protein
- artificial intelligence